EVAX
Price
$3.42
Change
+$0.37 (+12.13%)
Updated
Jun 22 closing price
Capitalization
28.94M
58 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$3.18
Change
-$0.05 (-1.55%)
Updated
Jun 22 closing price
Capitalization
1.68B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EVAX vs RXRX

EVAX vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
EVAX vs. RXRX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a Hold and RXRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (EVAX: $3.47 vs. RXRX: $3.16)
Brand notoriety: EVAX and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 87% vs. RXRX: 83%
Market capitalization -- EVAX: $28.94M vs. RXRX: $1.68B
EVAX [@Biotechnology] is valued at $28.94M. RXRX’s [@Biotechnology] market capitalization is $1.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • EVAX’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both EVAX and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 2 bullish TA indicator(s).

  • EVAX’s TA Score: 4 bullish, 4 bearish.
  • RXRX’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, EVAX is a better buy in the short-term than RXRX.

Price Growth

EVAX (@Biotechnology) experienced а -3.61% price change this week, while RXRX (@Biotechnology) price change was -3.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was +3.26%, and the average quarterly price growth was +1969.89%.

Reported Earning Dates

EVAX is expected to report earnings on Aug 20, 2026.

RXRX is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.68B) has a higher market cap than EVAX($28.9M). RXRX YTD gains are higher at: -22.616 vs. EVAX (-27.254). EVAX has higher annual earnings (EBITDA): -9.88M vs. RXRX (-478.66M). RXRX has more cash in the bank: 654M vs. EVAX (18.4M). EVAX has less debt than RXRX: EVAX (11.3M) vs RXRX (72.4M). RXRX has higher revenues than EVAX: RXRX (65.7M) vs EVAX (7.53M).
EVAXRXRXEVAX / RXRX
Capitalization28.9M1.68B2%
EBITDA-9.88M-478.66M2%
Gain YTD-27.254-22.616121%
P/E RatioN/AN/A-
Revenue7.53M65.7M11%
Total Cash18.4M654M3%
Total Debt11.3M72.4M16%
TECHNICAL ANALYSIS
Technical Analysis
EVAXRXRX
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 29 days ago
84%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
EVAX
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRLS1.31N/A
N/A
Borealis Foods
DOLE13.87-0.13
-0.93%
Dole plc
TKNO5.14-0.10
-1.91%
Alpha Teknova
BKNG167.77-4.01
-2.33%
Booking Holdings Inc.
OWL9.23-0.30
-3.15%
Blue Owl Capital

EVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVAX has been loosely correlated with OMER. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EVAX jumps, then OMER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
+13.77%
OMER - EVAX
37%
Loosely correlated
+0.44%
ABSI - EVAX
36%
Loosely correlated
+13.50%
RXRX - EVAX
35%
Loosely correlated
-2.01%
CYPH - EVAX
34%
Loosely correlated
-2.19%
ABOS - EVAX
29%
Poorly correlated
+5.53%
More